AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹657 Cr | ₹694 Cr | ₹601 Cr | ₹581 Cr | ₹0.02 Cr |
What is the latest Total Current Liabilities ratio of AARTI PHARMALABS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹657 Cr |
| Mar2024 | ₹694 Cr |
| Mar2023 | ₹601 Cr |
| Mar2022 | ₹581 Cr |
| Mar2021 | ₹0.02 Cr |
How is Total Current Liabilities of AARTI PHARMALABS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹657 Cr | -5.38 | |
| Mar2024 | ₹694 Cr | 15.61 | |
| Mar2023 | ₹601 Cr | 3.44 | |
| Mar2022 | ₹581 Cr | 2,639,286.36 | |
| Mar2021 | ₹0.02 Cr | - | |
Compare Total Current Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹6,115.4 Cr | -3.5% | -5.1% | -31.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | -3.5% |
-5.1% |
-31.1% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses